logo

CTOR

Citius Oncology·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
3.19 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Should I Buy CTOR Now?
  • Based on a composite score of 3.19/10, we rate CTOR as a Netural. Our analysis breaks down into 0.81/10 for Fundamentals, 4.36/10 for Technicals, and 3.80/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is CTOR fundamentally strong?
What is the current technical signals for CTOR?
What is the market sentiment for CTOR?